Cassava Sciences, Inc. (SAVA)

2.85 -0.08 (-2.73%) USD  |  NASDAQ  |  Dec 15, 13:20
More

Cassava Sciences Cash and Short Term Investments (Quarterly): 106.08M for Sept. 30, 2025

Cash and Short Term Investments (Quarterly) Chart

View Cash and Short Term Investments (Quarterly) for SAVA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Cash and Short Term Investments Definition

View Cash and Short Term Investments Definition
Start Trial

Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.

Read full definition.

Cash and Short Term Investments (Quarterly) Range, Past 5 Years

View Cash and Short Term Investments (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Quarterly) Benchmarks

View Cash and Short Term Investments (Quarterly) Benchmarks
Start Trial
Biogen, Inc. 3.960B
Geron Corp. 382.41M
Ovid Therapeutics, Inc. 25.60M
NovaBay Pharmaceuticals, Inc. 2.309M
Palatin Technologies, Inc. 1.273M